« Previous
Next »
Urologic Oncology: Seminars and Original Investigations
Volume 30, Issue 1
, Pages
16-20
, January 2012
GREB1 tissue expression is associated with organ-confined prostate cancer
-
Relative expression of the four genes in the malignant prostatic tissue according to serum PSA value. Fold change in gene expression was calculated using the ΔΔCT method (QRel = 27−ΔΔCT). Results are
Relative expression of the four genes in the malignant prostatic tissue according to serum PSA value. Fold change in gene expression was calculated using the ΔΔCT method (QRel = 27−ΔΔCT). Results are shown as a box plot with percentile values.
-
Relative expression of the four genes in the malignant prostatic tissue according to Gleason score. Fold change in gene expression was calculated using the ΔΔCT method (QRel = 27−ΔΔCT). Results are shRelative expression of the four genes in the malignant prostatic tissue according to Gleason score. Fold change in gene expression was calculated using the ΔΔCT method (QRel = 27−ΔΔCT). Results are shown as a box plot with percentile values.
-
Relative expression of the four genes in the malignant prostatic tissue according to pathologic stage. Fold change in gene expression was calculated using the ΔΔCT method (QRel = 27−ΔΔCT). Results areRelative expression of the four genes in the malignant prostatic tissue according to pathologic stage. Fold change in gene expression was calculated using the ΔΔCT method (QRel = 27−ΔΔCT). Results are shown as a box plot with percentile values.
-
Relative expression of the four genes in the malignant prostatic tissue according to biochemical recurrence status. Fold change in gene expression was calculated using the ΔΔCT method (QRel = 27−ΔΔCT)Relative expression of the four genes in the malignant prostatic tissue according to biochemical recurrence status. Fold change in gene expression was calculated using the ΔΔCT method (QRel = 27−ΔΔCT). Results are shown as a box plot with percentile values.
☆ This study was supported by FAPESP (Fundação de Amparo à Pesquisa do Estado de Sao Paulo) under the protocol number 2006/56492-5.
PII: S1078-1439(09)00295-6
doi: 10.1016/j.urolonc.2009.09.014
© 2012 Elsevier Inc. All rights reserved.
« Previous
Next »
Urologic Oncology: Seminars and Original Investigations
Volume 30, Issue 1
, Pages
16-20
, January 2012
